17 evolution-"https:"-"https:"-"https:"-"https:"-"https:" uni jobs at Ghent University
Sort by
Refine Your Search
-
Department PS05 - Department of Conflict and Development Studies Degree Masters Diploma Occupancy rate 100% Vacancy type Research staff ABOUT GHENT UNIVERSITY The Conflict Research Group (CRG) , based
-
Bekijk Nederlandstalige versie The Industrial Research Fund (IOF) supports the development of application-oriented knowledge and technology and its transfer to business, government and the non
-
not offer protection against infections with gut pathogens. Oral vaccines hold much promise to protect against these pathogens, but their development is challenging due to the poor uptake of vaccines by
-
to society. The Erasmus+ funding is not designed to directly pay for any activities related to the preparation or development of applications to any other funding programmes. Pure research projects are not
-
? Equipment: The purchase of (components for) the research infrastructure or the upgrade of already existing infrastructure Staff costs: For the development and construction or permanent operation of
-
extensive training and professional development opportunities, 36 days of annual holiday leave (for a full-time position), additional fixed bridge days, a bicycle allowance, and eco vouchers. Click here
-
a constructive working environment that offers plenty of opportunities for further development and training, including the possibility of taking courses at the Doctoral Schools. You will work in the
-
Büscher at the Department of Conflict & Development Studies, Faculty of Political and Social Sciences. CRG is a multidisciplinary research unit that studies the larger social dynamics of civil conflict and
-
in patients, and 3) the development of innovative strategies for eradicating HIV reservoirs. In addition, we aim to take our innovations to the clinical stage, conducting trials that push the
-
in patients, and 3) the development of innovative strategies for eradicating HIV reservoirs. In addition, we aim to take our innovations to the clinical stage, conducting trials that push the